3M completed a spinoff of its healthcare business, Solventum, on Monday. The company started trading on the New York Stock Exchange under the ticker SOLV and was quoted at $67.96 a share at midday.

The newly public Solventum Corp., the spinoff of 3M’s health care business, has raised its full-year financial guidance as its leaders work to establish a road map for the organization going forward.

(Photo by: Michael Siluk/Education Images/Universal Images Group via Getty Images) On February 21, 2024, 3M Company (NYSE: MMM, $91.82, Market Capitalization: $50.7 billion), a diversified global ...

Solventum, Minnesota’s newest Fortune 500 company, is finding its footing after starting its first full year of operations on shakier ground. The 3M spinoff commenced 2025 with a deflated stock, which ...

Over a year after announcing plans to spin out its healthcare business as a standalone company, 3M has finally revealed the name of that soon-to-be-formed entity. 3M appears to have chosen the latter, ...

Solventum Corporation, the spinoff of 3M's healthcare business, has started trading as a separate entity. The company is a global healthcare company with a broad portfolio of solutions and generated ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Activist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum, ...

New York-based Trian Partners, a high-profile hedge fund and multi-billion dollar investment management firm, is buying up shares in Minnesota's Solventum, the spinoff of 3M's health care business, ...